BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19486027)

  • 21. The safety of sublingual immunotherapy with one or multiple pollen allergens in children.
    Agostinis F; Foglia C; Landi M; Cottini M; Lombardi C; Canonica GW; Passalacqua G
    Allergy; 2008 Dec; 63(12):1637-9. PubMed ID: 19032238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
    Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
    Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A; Confino-Cohen R
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multicenter drug surveillance of sublingual immunotherapy in allergic patients].
    Almagro E; Asensio O; Bartolomé JM; Bosque M; de la Hoz B; Dolz I; Elorza J; Ferreiro M; García JM; Losada E
    Allergol Immunopathol (Madr); 1995; 23(4):153-9. PubMed ID: 8553989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
    Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of patients with allergic polysensitization: the POLISMAIL study.
    Ciprandi G; Alesina R; Ariano R; Aurnia P; Borrelli P; Cadario G; Capristo A; Carosso A; Casino G; Castiglioni G; Cesinaro Di Rocco P; Colangelolo C; Di Gioacchino M; Di Paola MG; Errico G; Fiorina A; Gambuzza F; Gangemi S; Gasparini A; Giugno R; Iemoli E; Isola S; Maniero G; Marengo F; Mazzali P; Minelli M; Mosca M; Pellegrino R; Piconi S; Pravettoni V; Quaglio L; Ricciardi L; Ridolo E; Sillano V; Valle C; Varin E; Verini M; Zambito M; Riario-Sforza GG; Incorvaia C; Puccinelli P; Scurati S; Frati F
    Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):77-83. PubMed ID: 19334371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience.
    Ragusa FV; Passalacqua G; Gambardella R; Campanari S; Barbieri MM; Scordamaglia A; Canonica GW
    J Investig Allergol Clin Immunol; 1997; 7(3):151-4. PubMed ID: 9252872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorrect allergy injections: allergists' experiences and recommendations for prevention.
    Aaronson DW; Gandhi TK
    J Allergy Clin Immunol; 2004 Jun; 113(6):1117-21. PubMed ID: 15208593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pattern of indoor and outdoor respiratory allergens in asthmatic adult patients in a humid and desert newly developed country.
    Sattar HA; Mobayed H; al-Mohammed AA; Ibrahim AS; Jufairi AA; Balamurugan P; Mary VP; Bener A
    Eur Ann Allergy Clin Immunol; 2003 Oct; 35(8):300-5. PubMed ID: 14653049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy units: a follow-up study.
    Machín IS; Robaina JCG ; Bonnet C; de Blas C; Fernández-Caldas E; Triviño MS; de la Morin FT
    J Investig Allergol Clin Immunol; 2001; 11(3):167-71. PubMed ID: 11831448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic reactions due to allergen immunotherapy.
    Karaayvaz M; Erel F; Caliskaner Z; Ozangüç N
    J Investig Allergol Clin Immunol; 1999; 9(1):39-44. PubMed ID: 10212856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of ultrashort-term sit with pollen allergoids adjuvanted by monophosphoryl lipid A: a prospective Italian survey.
    Crivellaro M; Senna GE; Pappacoda A; Vanzelli R; Spacal B; Marchi G; Recchia G; Makatsori M
    Eur Ann Allergy Clin Immunol; 2011 Mar; 43(2):58-60. PubMed ID: 21608374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
    Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
    Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma.
    Tabar AI; Lizaso MT; García BE; Echechipía S; Olaguibel JM; Rodríguez A
    J Investig Allergol Clin Immunol; 2000; 10(6):327-33. PubMed ID: 11206932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010.
    Santos N; Pereira AM; Silva R; Torres da Costa J; Plácido JL
    Allergol Immunopathol (Madr); 2015; 43(1):25-31. PubMed ID: 24661594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety profile of subcutaneous allergen immunotherapy in children with asthma in Hangzhou, East China.
    Liu JL; Ning WX; Li SX; Xu YC; Wu L; Wang YS; Xu XF; Jiang Y; Sheng YJ; Zhou YL; Wang JH; Tang LF; Chen ZM
    Allergol Immunopathol (Madr); 2017; 45(6):541-548. PubMed ID: 28629672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergy immunotherapy as an early intervention in patients with child-onset atopic asthma.
    Nagaya H; Maren S; Nagaya N
    Int Arch Allergy Immunol; 2006; 139(1):9-15. PubMed ID: 16272821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application.
    Ullrich D; Ullrich K; Mussler S; Thum-Oltmer S
    Eur Ann Allergy Clin Immunol; 2015 Jan; 47(1):10-4. PubMed ID: 25599553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.